BIO Key Earnings Estimate

BKYI Stock  USD 1.73  0.38  18.01%   
The next projected EPS of BIO Key is estimated to be 0.0 with future projections ranging from a low of 0.0 to a high of 0.0. BIO Key's most recent 12-month trailing earnings per share (EPS TTM) is at -8.66. Please be aware that the consensus of earnings estimates for BIO Key International is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
BIO Key is projected to generate 0.0 in earnings per share on the 31st of December 2023. BIO Key earnings estimates show analyst consensus about projected BIO Key International EPS (Earning Per Share). It derives the highest and the lowest estimates based on BIO Key's historical volatility. Many public companies, such as BIO Key, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

BIO Key Revenue Breakdown by Earning Segment

By analyzing BIO Key's earnings estimates, investors can diagnose different trends across BIO Key's analyst sentiment over time as well as compare current estimates against different timeframes. The BIO Key's current Gross Profit is estimated to increase to about 3.2 M, while Pretax Profit Margin is forecasted to increase to (1.22).
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

BIO Key Earnings Estimation Breakdown

The calculation of BIO Key's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of BIO Key is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for BIO Key International is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.08
0.00
Lowest
Expected EPS
0.0
0.00
Highest

BIO Key Earnings Projection Consensus

Suppose the current estimates of BIO Key's value are higher than the current market price of the BIO Key stock. In this case, investors may conclude that BIO Key is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and BIO Key's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2023Current EPS (TTM)
135.08%
-0.08
0.0
-8.66

BIO Key Earnings per Share Projection vs Actual

Actual Earning per Share of BIO Key refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering BIO Key International predict the company's earnings will be in the future. The higher the earnings per share of BIO Key, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

BIO Key Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as BIO Key, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of BIO Key should always be considered in relation to other companies to make a more educated investment decision.

BIO Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact BIO Key's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-18
2024-09-30-0.58-0.3910.18932 
2024-08-14
2024-06-30-0.54-1.0-0.4685 
2024-06-17
2024-03-31-4.14-2.881.2630 
2023-10-25
2023-09-30-0.2-0.080.1260 
2023-08-14
2023-06-30-0.23-0.160.0730 
2023-05-16
2023-03-31-0.27-0.080.1970 
2023-03-31
2022-12-31-0.27-0.4-0.1348 
2022-11-14
2022-09-30-0.16-0.29-0.1381 
2022-08-12
2022-06-30-0.08-0.21-0.13162 
2022-05-16
2022-03-31-0.22-0.120.145 
2022-03-29
2021-12-31-0.15-0.26-0.1173 
2021-11-15
2021-09-30-0.11-0.13-0.0218 
2021-08-16
2021-06-30-0.11-0.15-0.0436 
2021-05-14
2021-03-31-0.16-0.090.0743 
2021-03-25
2020-12-31-0.16-0.18-0.0212 
2020-11-12
2020-09-30-0.08-0.48-0.4500 
2020-08-14
2020-06-30-0.24-0.56-0.32133 
2020-05-14
2020-03-31-0.24-1.36-1.12466 
2019-12-31
2019-12-31-0.24-1.36-1.12466 
2019-11-14
2019-09-30-0.4-1.04-0.64160 
2019-08-14
2019-06-30-0.4-0.56-0.1640 
2019-05-15
2019-03-31-0.32-1.04-0.72225 
2018-12-31
2018-12-310.06-0.1-0.16266 
2018-11-14
2018-09-30-0.06-0.96-0.91500 
2018-08-14
2018-06-30-0.48-1.2-0.72150 
2018-05-15
2018-03-31-1.6-2.4-0.850 
2018-03-29
2017-12-31-0.160.320.48300 
2017-11-14
2017-09-30-1.36-2.24-0.8864 
2017-08-14
2017-06-30-1.76-2.56-0.845 
2017-05-15
2017-03-31-0.22-0.26-0.0418 
2017-03-31
2016-12-310-0.12-0.12
2016-11-14
2016-09-30-0.96-1.92-0.96100 
2007-08-14
2007-06-30-3.84-9.6-5.76150 

About BIO Key Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of BIO Key earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current BIO Key estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as BIO Key fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-112.5 M-106.9 M
Retained Earnings Total Equity-89.6 M-85.1 M
Earnings Yield(5.83)(5.54)
Price Earnings Ratio(0.18)(0.17)
Price Earnings To Growth Ratio 0.01  0.01 

Currently Active Assets on Macroaxis

When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.66)
Revenue Per Share
6.323
Quarterly Revenue Growth
(0.41)
Return On Assets
(0.56)
Return On Equity
(4.58)
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.